Stoke Therapeutics, Inc. (STOK)
25.04
-0.66
(-2.57%)
USD |
NASDAQ |
Oct 23, 16:00
25.03
-0.01
(-0.04%)
After-Hours: 20:00
Stoke Therapeutics Price : 25.04 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 25.53 | 25.83 | 24.80 | 25.04 | 2.156M |
| Oct 22, 2026 | 25.88 | 26.72 | 25.64 | 25.70 | 1.346M |
| Oct 21, 2026 | 26.83 | 27.22 | 25.31 | 25.68 | 2.258M |
| Oct 20, 2026 | 24.95 | 27.22 | 24.84 | 26.61 | 2.459M |
| Oct 19, 2026 | 24.49 | 25.02 | 24.13 | 24.82 | 711015.0 |
| Oct 16, 2026 | 24.56 | 24.61 | 23.64 | 24.17 | 880149.0 |
| Oct 15, 2026 | 23.54 | 24.62 | 23.45 | 24.61 | 818176.0 |
| Oct 14, 2026 | 22.43 | 23.36 | 22.05 | 23.26 | 1.090M |
| Oct 13, 2026 | 24.05 | 24.06 | 22.30 | 22.50 | 618021.0 |
| Oct 12, 2026 | 24.65 | 24.67 | 24.10 | 24.15 | 372992.0 |
| Oct 09, 2026 | 23.98 | 25.20 | 23.79 | 24.74 | 918956.0 |
| Oct 08, 2026 | 24.04 | 24.29 | 23.64 | 23.95 | 692278.0 |
| Oct 07, 2026 | 24.13 | 24.70 | 23.95 | 24.29 | 637097.0 |
| Oct 06, 2026 | 25.58 | 25.72 | 23.00 | 24.37 | 1.167M |
| Oct 05, 2026 | 25.82 | 26.31 | 24.84 | 25.32 | 928392.0 |
| Oct 02, 2026 | 26.46 | 26.46 | 25.45 | 25.62 | 848622.0 |
| Oct 01, 2026 | 26.06 | 26.51 | 25.91 | 26.01 | 1.161M |
| Sep 30, 2026 | 26.12 | 26.69 | 25.88 | 26.00 | 1.875M |
| Sep 29, 2026 | 25.30 | 25.99 | 25.12 | 25.88 | 1.077M |
| Sep 28, 2026 | 24.51 | 25.71 | 24.20 | 25.50 | 1.660M |
| Sep 25, 2026 | 25.47 | 25.52 | 24.80 | 24.80 | 1.218M |
| Sep 24, 2026 | 26.09 | 26.30 | 25.00 | 25.29 | 1.220M |
| Sep 23, 2026 | 29.22 | 29.22 | 26.02 | 26.11 | 1.202M |
| Sep 22, 2026 | 28.44 | 29.40 | 28.24 | 29.20 | 527225.0 |
| Sep 21, 2026 | 28.80 | 28.80 | 27.75 | 28.05 | 720047.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 6.33 |
| Amgen, Inc. | 439.26 |
| Anika Therapeutics, Inc. | 21.42 |
| BioCryst Pharmaceuticals, Inc. | 7.65 |
| Imunon, Inc. | 1.235 |
Price Related Metrics
| PS Ratio | 55.84 |
| Price to Book Value | 4.522 |
| Earnings Yield | -13.47% |
| Market Cap | 1.563B |